New combo therapy targets tough lung cancer

NCT ID NCT05765825

NEW Ongoing Disease control Sponsor: Sichuan University Source: ClinicalTrials.gov ↗

First seen Apr 30, 2026 · Last updated Apr 30, 2026

Summary

This study tests a new treatment for people with extensive-stage small cell lung cancer who have not had treatment before. It combines low-dose radiation with standard chemotherapy and an immunotherapy drug. The goal is to see if this combination can help control the cancer longer. 61 participants are being enrolled at multiple centers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cancer Hospital of Shantou University Medical College

Shantou, Guangdong, 515041, China
China West Hospital

Chengdu, Sichuan, 610000, China
Chongqing University cancer hospital

Chongqing, Chongqing Municipality, 400030, China
Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, 200032, China
GuiZhou Provincial People's Hospital

Guiyang, China
LiaoNing Cancer Hospital & Institute

Shenyang, Liaoning, 110801, China
Shandong Provincial Hospital

Jinan, Shandong, 250021, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430022, China

Conditions

Explore the condition pages connected to this study.

EXTENSIVE STAGE SMALL CELL LUNG CANCER